Description

The International Generics Program (IGP) is one of the first programs of its kind to be launched by a Canadian Prescription Broker in response to Big Pharma's increased pressure on Canadian prescription companies like ours. Just as its name implies, the International Generics Program is aimed at providing customers with the generic versions of medications that are currently only available as brand names in Canada. All pharmaceuticals obtained through IGP are the generic equivalents of approved brand name drugs. Most of these prescription drugs are manufactured in UK MHRA, Australian TGA, US Food and Drug Administration, German PIC and Health Canada inspected facilities located overseas in India. Moreover, they can be purchased at hefty discount prices above and beyond our already low prices on Canadian medications.